Nurdan Gamze TASLI, Yücel KARAKURT, Nurdagül AKTAŞ, Sumeyye Burcu AGCAYAZI, Hayati YILMAZ, Erel İÇEL, Turgay UÇAK

Anterior segment parameters and corneal specular microscopy findings in rheumatoid arthritis

Aim: To compare the anterior segment parameters and specular microscopy findings between patients with Rheumatoid arthritis(RA) and healthy controls.Material and Methods: In this prospective study, 55 patients diagnosed with RA and age and matched 55 control subjects without anysystemic diseases were enrolled. Central corneal thickness (CCT), corneal endothelial cell density (cells/mm2) (ECD), percentage ofhexagonal cells of corneal endothelial cells ( HEX), and cell size variability (CV%) of endothelial cells were measured using noncontactspecular microscopy (CEM-530 Specular Mıcroscope, NIDEK ).Anterior chamber depth (ACD), Axial Length (AL), white to white limbus length and keratometry were measured using an ocularbiometry system. In all patients of RA group, disease activity severity was assessed with The Disease Activity Score in 28 jointsdiseases activity score (DAS28 rate).Results: There were statistically significant differences between RA patients and control subjects regarding ACD (3.06±0.43 vs3.24±0.31; p: 0.001), white to white limbus length (11.63±0.45 vs 11.76±0.38; p: 0.02), CV% (35.49±5.96 vs 32.02±5.22, p: 0.001)and hexagonality (67.31±4.66 vs 71.35±11.02; p: 0.001). In correlation analysis, there was a negative correlation between diseaseperiods and both ACD and CCT; while there was a negative correlation with the number of cells and endothelial cell density and DAS28 score.Conclusion: Although there was not a significant difference regarding endothelial cell density values in RA group compared withhealthy controls; there was a negative correlation between the disease activity and endothelial cell density. Moreover, CV% wassignificantly higher and hexagonality % was significantly lower in RA group; indicating the endothelial damage and increase in theexpected compensatory response.Further, larger studies are warranted to define the exact pathological mechanisms and clinical outcomes of this corneal endothelialdamage in RA patients.

PDF

___

1. Kumar BS, Suneetha P, Mohan A, et al. comparison of disease activity score in 28 joints with esr (das28), clinical disease activityindex (cdai), health assessment questionnaire disability index (haq-di) & amp; routine assessment of patient index data with 3 measures (rapid3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation. Indian J Med Res 2017;146:S57-S62.
2. Muñoz-Fernández S, Bustabad Reyes MS, Calvo Alén J, et al. biologic disease-modifying antirheumatic drug attributes in the first lines of treatment of rheumatoid arthritis. 2015 acordar project. Reumatol Clin 2018;14:90-6.
3. Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
4. Murray PI, Rauz S. The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis. Best Pract Res Clin Rheumatol 2016;30:802-25.
5. Can ME, Erten S, Can GD, et al. corneal biomechanical properties in rheumatoid arthritis. Eye Contact Lens 2015;41:382-5.
6. Taş M, Öner V, Özkaya E, et al. Evaluation of corneal biomechanical properties in patients with rheumatoid arthritis: a study by ocular response analyzer. Ocul Immunol Inflamm 2014;22:224-7.
7. Fuchs HA, Brooks RH, Callahan LF, et al. A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 1989;32:531-7.
8. Harris ED, Firestein GS. Clinical features of rheumatoid arthritis. In: Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS, editors. Kelley’s text book of rheumatology. 8th ed. Philadelphia: Saunders Elsevier; 2009. p. 1087.
9. Graf C, Cardoso G, Silva MB, et al. Intra ocular pressure in chronic users of oral glucocorticoids for rheumatoid arthritis. Acta Reumatol Port 2006;31:151-5.
10. Anayol MA, Bostancı B, Şekeroğlu MA, et al. Assessment of corneal densitometry in rheumatoid arthritis patientsç. Turk J Ophthalmol 2017;47:125-9.
11. Özcura F, Aktaş S, Özkan Y, et al. Central corneal thickness and corneal curvature in patients with rheumatoid arthritis. Int Ophthalmol 2017;37:159-63.
12. Atalay K, Ustun I, Cabuk KS, et al. How does rheumatoid arthritis affect corneal biomechanical properties?Int J Clin Exp Med 2016;9:4665-9.
13. Sevimli N, Karadag R, Madenci E, et al. Ocular surface findings in patients with rheumatoid arthritis under methotrexate or biological agent therapy.Cutan Ocul Toxicol 2017;36:48-51.
14. Markovitz E, Perry ZH, Tsumi E, et al. Ocular involvement and its’ manifestations in rheumatoid arthritis patients. Harefuah 2011;150:713-8.
15. Heinke M, Pohl C, Alten R, et al. Central corneal thickness and endothelial cell density in patients with rheumatoid arthritis investigative ophthalmology. Visual Sci 2011;52: 647.
16. Galgauskas S, Norvydaitė D, Krasauskaitė D, et al. Agerelated changes in corneal thickness and endothelial characteristics. Clin Interv Aging 2013;8:1445-50.
17. Jorge J, Queiros A, Peixoto-de-Matos SC, et al. Age-related changes of corneal endothelium in normal eyes with a non-contact specular microscope. Journal of Emmetropia 2010;1:132-9.
18. Yunliang S, Yuqiang H, Ying-Peng L, et al. Corneal endothelial cell density and morphology in healthy Chinese eyes. Cornea 2007;26:130-2.
19. Sahu PK, Das GK, Agrawal S, et al. comparative evaluation of corneal endothelium in diabetic patients undergoing phacoemulsification. Middle East Afr J Ophthalmol 2017;24:195-201.
20. Pekel G, Özbakış F, Bahar A, et al. Correlations of corneal optical densitometry, endothelial hexagonality percentage, and epithelium thickness. Curr Eye Res 2018;43:170-4. 887